Papers › leukemia › 8152787

Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial

The Lancet. Oncology · 01-7-2018 · 8152787 on PMC →

262 citations FWCI 25.18 Acute Myeloid Leukemia Research Trend

Citation data as of 2026-04-12 (OpenAlex).

Extracted findings

This paper hasn't been extracted into the knowledge graph yet. We're working through the corpus — 8152787 is in the queue.

In the meantime: Browse leukemia papers → · Ask about this topic → · Explore the graph →